Nisa Investment Advisors LLC Decreases Position in Option Care Health, Inc. (NASDAQ:OPCH)

Nisa Investment Advisors LLC lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 13.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,765 shares of the company’s stock after selling 1,924 shares during the period. Nisa Investment Advisors LLC’s holdings in Option Care Health were worth $430,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Financial Management Professionals Inc. purchased a new position in Option Care Health in the 3rd quarter valued at approximately $29,000. First Horizon Advisors Inc. purchased a new position in Option Care Health in the 3rd quarter valued at approximately $37,000. Advisors Asset Management Inc. boosted its position in Option Care Health by 121.4% in the 1st quarter. Advisors Asset Management Inc. now owns 1,337 shares of the company’s stock valued at $42,000 after buying an additional 733 shares during the period. NewEdge Advisors LLC boosted its position in Option Care Health by 1,031.9% in the 1st quarter. NewEdge Advisors LLC now owns 1,562 shares of the company’s stock valued at $50,000 after buying an additional 1,424 shares during the period. Finally, Headlands Technologies LLC boosted its position in Option Care Health by 5,796.7% in the 3rd quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock valued at $57,000 after buying an additional 1,739 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The shares were purchased at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the purchase, the director now directly owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is owned by company insiders.

Option Care Health Price Performance

Shares of OPCH opened at $30.27 on Thursday. Option Care Health, Inc. has a twelve month low of $24.23 and a twelve month high of $35.74. The firm’s fifty day simple moving average is $32.34 and its 200-day simple moving average is $31.59. The firm has a market capitalization of $5.26 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 1.76 and a beta of 1.22. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, February 22nd. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The business had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same period last year, the business earned $0.26 EPS. The company’s revenue was up 9.5% on a year-over-year basis. Equities analysts forecast that Option Care Health, Inc. will post 1.13 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have commented on OPCH shares. Jefferies Financial Group raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th. Barrington Research raised their price objective on shares of Option Care Health from $35.00 to $38.00 and gave the company an “outperform” rating in a report on Friday, February 23rd.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.